Navigation Links
Oramed Announces Successful Results from Ex-US Pharmacokinetic Study of its Oral Insulin for the Treatment of Type 1 Diabetes
Date:12/20/2013

ese forward-looking statements are based on the current expectations of the management of Oramed only, and are subject to a number of factors and uncertainties that could cause actual results to differ materially from those described in the forward-looking statements, including the risks and uncertainties related to the progress, timing, cost, and results of clinical trials and product development programs; difficulties or delays in obtaining regulatory approval or patent protection for our product candidates; competition from other pharmaceutical or biotechnology companies; and our ability to obtain additional funding required to conduct our research, development and commercialization activities. In addition, the following factors, among others, could cause actual results to differ materially from those described in the forward-looking statements: changes in technology and market requirements; delays or obstacles in launching our clinical trials; changes in legislation; inability to timely develop and introduce new technologies, products and applications; lack of validation of our technology as we progress further and lack of acceptance of our methods by the scientific community; inability to retain or attract key employees whose knowledge is essential to the development of our products; unforeseen scientific difficulties that may develop with our process; greater cost of final product than anticipated; loss of market share and pressure on pricing resulting from competition; laboratory results that do not translate to equally good results in real settings; our patents may not be sufficient; and final that products may harm recipients, all of which could cause the actual results or performance of Oramed to differ materially from those contemplated in such forward-looking statements. Except as otherwise required by law, Oramed undertakes no obligation to publicly release any revisions to these forward-looking statements to reflect events or circumstances after the da
'/>"/>
SOURCE Oramed Pharmaceuticals Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Oramed Receives Allowance on its Core Oral GLP-1 Technology Patent in Israel
2. Oramed Receives Patent in the European Union for the Oral Delivery of Insulin
3. Oramed Announces Last Patient Out in Phase 2a FDA Trial of its ORMD-0801 Oral Insulin Capsule
4. Orameds Platform Technology in Oral Delivery of Proteins Receives Patent in Russia
5. Oramed Granted Patent in China for its Platform Technology in Oral Delivery of Proteins
6. Oramed Submits Pre-IND Meeting Request to FDA for its Oral Exenatide Capsule ORMD-0901
7. Oramed to Raise $4,600,000 in Registered Direct Offering
8. Oramed Pharmaceuticals to Present Findings on Oral Insulin to the American Diabetes Association
9. Oramed Pharmaceuticals Announces Withdrawal of Proposed Underwritten Public Offering
10. Oramed Pharmaceuticals to Present at IATI-BioMed Conference in Israel
11. Oramed Selected to Present at the 81st European Atherosclerosis Society Congress in Lyon, France, June 2-5, 2013
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/19/2014)... 19, 2014   Lincor Inc. today ... technology to New Jersey -based ... CarePoint Health will deploy Lincor,s PatientLINC technology across ... Hospital and Hoboken University Medical Center. ... software solutions to help hospitals reach new levels ...
(Date:8/19/2014)...  The Alabama Supreme Court, in a 6-3 decision on ... who mislead doctors into believing that prescription medicines the companies ... v. Wyeth, and the decision came after the Supreme Court ... year. Heninger Garrison Davis attorneys Lew Garrison and ... Danny Weeks . The decision won a ...
(Date:8/19/2014)... , Aug. 19, 2014 Talyst, a market ... exhibiting at the 2014 NPPA Summer Conference in ... be showcasing its 340B software products and services.   ... splitting solutions, supplying over 400 customers with a variety ... 340B solutions including its latest solution, AutoSplit® Contract Pharmacy ...
Breaking Medicine Technology:Lincor Announces Agreement With CarePoint Health For State-Of-The-Art Patient Engagement Technology 2Heninger Garrison Davis Clients To Get Their Day in Court Against Brand Drug Companies 2Heninger Garrison Davis Clients To Get Their Day in Court Against Brand Drug Companies 3Heninger Garrison Davis Clients To Get Their Day in Court Against Brand Drug Companies 4Talyst Exhibits at the NPPA Summer Conference 2
(Date:8/19/2014)... The National Cannabis Industry Association ... Symposium on Saturday, August 23, from 9:45am to ... Vegas. , Featuring keynotes by U.S. Representative Dina Titus ... the event will also include in-depth discussions on marijuana-infused ... doing federally to advance a legitimate and responsible cannabis ...
(Date:8/19/2014)... Plains, NY (PRWEB) August 19, 2014 ... they were named the winner of the 2014 ... Naturals took home the first place position in ... the marketplace specially-formatted eyeliner, which also includes a ... rich black color, plus lash-boosting technology. ...
(Date:8/19/2014)... 19, 2014 Just back from Glasgow where ... Booklets at the Commonwealth Games (July 23 – August ... kids stay off drugs. And the need for his work ... 850,000 people age16 to 59 consumed Class A drugs within ... abusing New Psychoactive Substances (NPS) drugs considered to be “legal ...
(Date:8/19/2014)... stay and could use this time as an opportunity to ... home. Now a study published in the August 20 ... the proportion of hospitalized smokers who successfully quit smoking after ... interactive voice response technology automated telephone calls to ... left the hospital. , "Most smokers want to ...
(Date:8/19/2014)... Program has selected three geriatric social work ... development and mentorship for projects that will improve ... for all older adults. , The 2014 Hartford/VA ... among veterans, transitions from VA nursing facilities back ... older veterans. The Hartford/VA Geriatric Scholars Program provides ...
Breaking Medicine News(10 mins):Health News:SATURDAY IN LAS VEGAS: U.S. Rep. Dina Titus, State Sen. Tick Segerblom Keynote National Cannabis Industry Association Southwest CannaBusiness Symposium 2Health News:GrandeLINER™ Wins Independent Cosmetics Manufacturers & Distributors Award 2Health News:GrandeLINER™ Wins Independent Cosmetics Manufacturers & Distributors Award 3Health News:British Scientologist on a Mission to Save Youth from Drug Abuse 2Health News:Extended support helps patients stay smoke-free after hospital discharge 2
... The Kerlan Jobe Orthopaedic Clinic, a sports medicine clinic in ... million to settle allegations that it received illegal kickbacks from ... , The settlement resolves allegations that HealthSouth paid ... grants, donations to the Kerlan Jobe Foundation, loan forgiveness on ...
... , LOS ANGELES, Dec. 1 A decision issued ... Board (NLRB) has put at risk the guaranteed raises, healthcare ... professionals in Southern California. , "We have worked for years ... allow us to provide the professional care our patients need," ...
... tomography (CT) imaging of changes in tumors from colorectal ... have the potential to predict overall survival, according to ... JAMA . The addition of bevacizumab to ... survival in patients with stage IV colorectal cancer and ...
... , , ... (ASH) will host its annual High School Student Symposium at ... a.m. CST. The symposium, which encourages an interest in hematology, ... with the Society,s 51st Annual Meeting. This year, students will ...
... , MEXICO CITY, Dec. 1 ... will build a world-class center for biomedical and nanomedical ... research and development will be integrated with the National ... in the world. The research complex, scheduled to ...
... , BELLEVUE, Wash., Dec 1 Edifecs, ... Channel Modernization solutions announced an enhanced release of Edifecs ... migrations. XEngine Translator provides out-of-the-box 4010A1-5010 conversion maps, allows ... 4010A1 and 5010 in production, thus addressing most requirements ...
Cached Medicine News:Health News:Los Angeles' Kerlan Jobe Orthopaedic Clinic Pays $3 Million to Settle Kickback Allegations 2Health News:Labor Board Decision Puts Kaiser Workers' Pay, Healthcare, Pensions in Jeopardy 2Health News:Criteria based on CT imaging after chemotherapy may help predict survival 2Health News:ASH to Encourage High School Students to Pursue Biomedical Research Through Special Symposium and Science Curriculum 2Health News:ASH to Encourage High School Students to Pursue Biomedical Research Through Special Symposium and Science Curriculum 3Health News:Mexico City to Build World-Class Hub for Medical Research 2Health News:Edifecs Delivers Enhanced HIPAA 4010A1 to 5010 Migration Capabilities for Healthcare Organizations 2Health News:Edifecs Delivers Enhanced HIPAA 4010A1 to 5010 Migration Capabilities for Healthcare Organizations 3
The ACMI TurboFlow 18 L and 10 L Insufflators provide rapid distention for all laparoscopic procedures. Eleven built-in safety features make insufflation reliable and dependable....
This multiple-function instrument allows the surgeon to grasp, coagulate, and transect tissue with a single instrument, eliminating the need for multiple instruments and, in some procedures, costly l...
Bipolar forceps...
... An in vitro Nucleic Acid ... using Microplate Chemiluminescence for the ... (HPV) Types 6,11,16,18,31,33,35,39,42,43,44,45,51,52,56,58,59 and 68 ... Lowand High-Risk Groups in Cervical ...
Medicine Products: